Vikram Khurana, M.B.,B.S., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
alpha-Synuclein | 18 | 2024 | 752 | 3.070 |
Why?
|
Multiple System Atrophy | 5 | 2024 | 130 | 2.010 |
Why?
|
Parkinson Disease | 16 | 2024 | 2878 | 1.650 |
Why?
|
Neurodegenerative Diseases | 8 | 2023 | 1085 | 1.250 |
Why?
|
Induced Pluripotent Stem Cells | 6 | 2024 | 1850 | 1.120 |
Why?
|
Supranuclear Palsy, Progressive | 2 | 2022 | 81 | 0.990 |
Why?
|
Cerebellar Ataxia | 2 | 2024 | 150 | 0.890 |
Why?
|
Inclusion Bodies | 1 | 2024 | 281 | 0.840 |
Why?
|
Proteostasis Deficiencies | 1 | 2020 | 39 | 0.680 |
Why?
|
Saccharomyces cerevisiae | 7 | 2018 | 2674 | 0.650 |
Why?
|
Neurons | 16 | 2024 | 9438 | 0.650 |
Why?
|
Ataxia | 1 | 2021 | 306 | 0.640 |
Why?
|
Prions | 2 | 2017 | 180 | 0.580 |
Why?
|
Tauopathies | 3 | 2012 | 320 | 0.550 |
Why?
|
Peroxidase | 1 | 2019 | 610 | 0.500 |
Why?
|
In Situ Hybridization | 1 | 2019 | 1900 | 0.480 |
Why?
|
Replication Protein C | 2 | 2024 | 25 | 0.480 |
Why?
|
Mass Spectrometry | 2 | 2019 | 2189 | 0.400 |
Why?
|
Cathepsin D | 1 | 2010 | 59 | 0.360 |
Why?
|
tau Proteins | 3 | 2010 | 2094 | 0.350 |
Why?
|
Protein Conformation | 1 | 2017 | 3965 | 0.340 |
Why?
|
Proteomics | 2 | 2020 | 3836 | 0.320 |
Why?
|
Drosophila | 5 | 2010 | 1494 | 0.300 |
Why?
|
Cell Cycle | 2 | 2006 | 2930 | 0.300 |
Why?
|
DNA Repeat Expansion | 2 | 2024 | 73 | 0.290 |
Why?
|
Neurotoxicity Syndromes | 1 | 2010 | 301 | 0.270 |
Why?
|
Nerve Degeneration | 2 | 2006 | 747 | 0.250 |
Why?
|
Lysosomes | 1 | 2010 | 924 | 0.240 |
Why?
|
Spinocerebellar Ataxias | 1 | 2005 | 105 | 0.230 |
Why?
|
Purkinje Cells | 1 | 2005 | 226 | 0.230 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18221 | 0.220 |
Why?
|
Stearoyl-CoA Desaturase | 2 | 2022 | 85 | 0.200 |
Why?
|
Genetic Testing | 1 | 2015 | 3533 | 0.200 |
Why?
|
DNA Damage | 1 | 2012 | 2446 | 0.200 |
Why?
|
Somatosensory Disorders | 1 | 2021 | 49 | 0.190 |
Why?
|
Decision Trees | 1 | 2022 | 504 | 0.180 |
Why?
|
Receptors, GABA | 1 | 2022 | 313 | 0.180 |
Why?
|
Point Mutation | 2 | 2019 | 1595 | 0.180 |
Why?
|
Pesticides | 1 | 2023 | 296 | 0.180 |
Why?
|
Drosophila melanogaster | 2 | 2008 | 1712 | 0.180 |
Why?
|
RNA Stability | 1 | 2022 | 320 | 0.170 |
Why?
|
Drosophila Proteins | 2 | 2006 | 1698 | 0.170 |
Why?
|
Animals | 20 | 2022 | 168201 | 0.160 |
Why?
|
Cytoprotection | 2 | 2018 | 200 | 0.140 |
Why?
|
Age of Onset | 1 | 2024 | 3302 | 0.140 |
Why?
|
Humans | 36 | 2024 | 760617 | 0.140 |
Why?
|
Eukaryotic Initiation Factor-4G | 1 | 2017 | 67 | 0.140 |
Why?
|
Gene Regulatory Networks | 2 | 2017 | 1745 | 0.140 |
Why?
|
Diagnosis, Differential | 2 | 2022 | 12966 | 0.130 |
Why?
|
Fatal Outcome | 1 | 2021 | 1835 | 0.130 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2006 | 2864 | 0.130 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2017 | 217 | 0.130 |
Why?
|
Models, Biological | 2 | 2010 | 9461 | 0.130 |
Why?
|
Saccharomyces cerevisiae Proteins | 2 | 2017 | 1836 | 0.130 |
Why?
|
Genome, Fungal | 1 | 2017 | 201 | 0.130 |
Why?
|
Syndrome | 1 | 2021 | 3268 | 0.120 |
Why?
|
Synapses | 1 | 2024 | 1755 | 0.120 |
Why?
|
Staining and Labeling | 1 | 2019 | 1081 | 0.120 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2467 | 0.120 |
Why?
|
Pedigree | 1 | 2021 | 4539 | 0.110 |
Why?
|
Yeasts | 1 | 2014 | 278 | 0.110 |
Why?
|
Celiac Disease | 1 | 2021 | 819 | 0.110 |
Why?
|
Rats | 5 | 2019 | 23717 | 0.100 |
Why?
|
Brain | 4 | 2024 | 27101 | 0.100 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2013 | 170 | 0.100 |
Why?
|
Amyloid | 1 | 2017 | 841 | 0.100 |
Why?
|
Endosomal Sorting Complexes Required for Transport | 1 | 2013 | 150 | 0.100 |
Why?
|
Heterozygote | 1 | 2019 | 2780 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2024 | 2570 | 0.090 |
Why?
|
Models, Animal | 1 | 2017 | 2109 | 0.090 |
Why?
|
DNA-Binding Proteins | 3 | 2017 | 9586 | 0.090 |
Why?
|
Neuroprotective Agents | 2 | 2017 | 957 | 0.090 |
Why?
|
Endoplasmic Reticulum | 1 | 2017 | 1132 | 0.090 |
Why?
|
Models, Neurological | 2 | 2015 | 1768 | 0.090 |
Why?
|
History, 21st Century | 1 | 2017 | 1565 | 0.090 |
Why?
|
Movement Disorders | 1 | 2014 | 459 | 0.090 |
Why?
|
Disease Susceptibility | 1 | 2017 | 1788 | 0.090 |
Why?
|
Apoptosis | 1 | 2006 | 9476 | 0.080 |
Why?
|
Disease | 1 | 2015 | 670 | 0.080 |
Why?
|
Compound Eye, Arthropod | 1 | 2008 | 3 | 0.080 |
Why?
|
Neuroglia | 1 | 2015 | 955 | 0.080 |
Why?
|
Alzheimer Disease | 3 | 2022 | 8601 | 0.080 |
Why?
|
Cholecalciferol | 1 | 2013 | 553 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 17878 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2013 | 858 | 0.080 |
Why?
|
Protein Folding | 2 | 2015 | 870 | 0.070 |
Why?
|
Cells, Cultured | 3 | 2019 | 18937 | 0.070 |
Why?
|
Genome-Wide Association Study | 3 | 2024 | 12661 | 0.070 |
Why?
|
Sheep | 1 | 2010 | 1436 | 0.070 |
Why?
|
Caspases | 1 | 2010 | 878 | 0.070 |
Why?
|
Gerstmann-Straussler-Scheinker Disease | 1 | 2006 | 10 | 0.070 |
Why?
|
Cerebral Cortex | 2 | 2019 | 5776 | 0.070 |
Why?
|
Signal Transduction | 2 | 2006 | 23416 | 0.070 |
Why?
|
Skin | 1 | 2019 | 4473 | 0.060 |
Why?
|
Amyloid beta-Peptides | 2 | 2017 | 3839 | 0.060 |
Why?
|
Models, Genetic | 1 | 2015 | 3431 | 0.060 |
Why?
|
In Situ Nick-End Labeling | 1 | 2006 | 613 | 0.060 |
Why?
|
Pluripotent Stem Cells | 1 | 2011 | 796 | 0.060 |
Why?
|
Magnetic Resonance Imaging | 2 | 2022 | 36402 | 0.060 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2005 | 247 | 0.060 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2013 | 1894 | 0.060 |
Why?
|
Vitamin D Deficiency | 1 | 2013 | 1388 | 0.060 |
Why?
|
Phosphorylation | 2 | 2019 | 8311 | 0.050 |
Why?
|
Microtubules | 1 | 2008 | 1073 | 0.050 |
Why?
|
Fatty Acids | 2 | 2022 | 1808 | 0.050 |
Why?
|
Stem Cells | 1 | 2015 | 3516 | 0.050 |
Why?
|
RNA, Messenger | 1 | 2017 | 12758 | 0.050 |
Why?
|
Vestibular Diseases | 1 | 2024 | 231 | 0.050 |
Why?
|
Mice | 6 | 2022 | 81368 | 0.050 |
Why?
|
Motor Skills | 1 | 2004 | 521 | 0.040 |
Why?
|
Proteins | 1 | 2015 | 6030 | 0.040 |
Why?
|
Mutation | 2 | 2022 | 30016 | 0.040 |
Why?
|
Enzyme Activation | 1 | 2006 | 3591 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2017 | 11874 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2024 | 858 | 0.040 |
Why?
|
Actins | 1 | 2006 | 2050 | 0.040 |
Why?
|
Cell Division | 1 | 2006 | 4457 | 0.040 |
Why?
|
Protein Kinases | 1 | 2006 | 1606 | 0.040 |
Why?
|
Oxadiazoles | 1 | 2018 | 94 | 0.040 |
Why?
|
Motor Endplate | 1 | 1998 | 20 | 0.040 |
Why?
|
Amphibians | 1 | 1998 | 29 | 0.040 |
Why?
|
Blotting, Western | 1 | 2006 | 5034 | 0.040 |
Why?
|
Nevada | 1 | 2017 | 22 | 0.040 |
Why?
|
Adrenergic beta-1 Receptor Agonists | 1 | 2017 | 14 | 0.040 |
Why?
|
Prospective Studies | 1 | 2022 | 54360 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2006 | 2057 | 0.030 |
Why?
|
Synaptic Vesicles | 1 | 1998 | 190 | 0.030 |
Why?
|
Albuterol | 1 | 2017 | 213 | 0.030 |
Why?
|
Organoids | 1 | 2022 | 744 | 0.030 |
Why?
|
Norway | 1 | 2017 | 499 | 0.030 |
Why?
|
Motor Cortex | 1 | 2004 | 1007 | 0.030 |
Why?
|
Aged | 4 | 2024 | 169042 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2024 | 2112 | 0.030 |
Why?
|
Propranolol | 1 | 2017 | 490 | 0.030 |
Why?
|
Antibodies | 1 | 2024 | 2414 | 0.030 |
Why?
|
Substantia Nigra | 1 | 2017 | 350 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2006 | 11069 | 0.030 |
Why?
|
Patient Advocacy | 1 | 2017 | 360 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2010 | 14389 | 0.030 |
Why?
|
Cell Line | 2 | 2024 | 15576 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1055 | 0.030 |
Why?
|
Learning | 1 | 2004 | 1740 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26049 | 0.030 |
Why?
|
Memory | 1 | 2004 | 2192 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2022 | 80566 | 0.030 |
Why?
|
Male | 6 | 2024 | 360358 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2017 | 730 | 0.030 |
Why?
|
Alleles | 1 | 2024 | 6861 | 0.030 |
Why?
|
Protein Stability | 1 | 2015 | 578 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2024 | 2985 | 0.030 |
Why?
|
Aging | 1 | 2012 | 8699 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15828 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2015 | 813 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1241 | 0.020 |
Why?
|
Protein Transport | 1 | 2017 | 1966 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2005 | 5789 | 0.020 |
Why?
|
Triglycerides | 1 | 2018 | 2459 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2017 | 1360 | 0.020 |
Why?
|
Ligands | 1 | 2017 | 3268 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2018 | 1896 | 0.020 |
Why?
|
Phenotype | 2 | 2024 | 16571 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2013 | 1333 | 0.020 |
Why?
|
Oligonucleotides | 1 | 2011 | 566 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2013 | 733 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4269 | 0.020 |
Why?
|
Mutagenesis | 1 | 2011 | 1230 | 0.020 |
Why?
|
Disease Progression | 1 | 2024 | 13495 | 0.020 |
Why?
|
Histones | 1 | 2017 | 2577 | 0.020 |
Why?
|
Middle Aged | 4 | 2024 | 220584 | 0.020 |
Why?
|
Promoter Regions, Genetic | 1 | 2017 | 5780 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2011 | 931 | 0.020 |
Why?
|
Risk | 1 | 2017 | 9604 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15908 | 0.010 |
Why?
|
Caenorhabditis elegans | 1 | 2013 | 1452 | 0.010 |
Why?
|
Embryonic Stem Cells | 1 | 2011 | 1262 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7583 | 0.010 |
Why?
|
Female | 5 | 2024 | 392148 | 0.010 |
Why?
|
Electromagnetic Fields | 1 | 2004 | 289 | 0.010 |
Why?
|
Thumb | 1 | 2004 | 232 | 0.010 |
Why?
|
Research Design | 1 | 2017 | 6174 | 0.010 |
Why?
|
Animals, Genetically Modified | 1 | 2006 | 1557 | 0.010 |
Why?
|
Cytoskeleton | 1 | 2006 | 1170 | 0.010 |
Why?
|
Child, Preschool | 1 | 2024 | 42188 | 0.010 |
Why?
|
Electrophysiology | 1 | 2004 | 1262 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2017 | 16967 | 0.010 |
Why?
|
Adult | 3 | 2024 | 220969 | 0.010 |
Why?
|
Electromyography | 1 | 2004 | 1393 | 0.010 |
Why?
|
Young Adult | 1 | 2024 | 59179 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2013 | 14591 | 0.010 |
Why?
|
Functional Laterality | 1 | 2004 | 2256 | 0.010 |
Why?
|
Exocytosis | 1 | 1998 | 320 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15689 | 0.010 |
Why?
|
Child | 1 | 2024 | 80079 | 0.010 |
Why?
|
Adolescent | 1 | 2024 | 88234 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2013 | 22148 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2004 | 1882 | 0.010 |
Why?
|
Endocytosis | 1 | 1998 | 955 | 0.010 |
Why?
|